I just learned of this study and wanted to share it with you, since this is a potential future ORAL medication that is not mentioned nearly as much as those from the larger MS pharmaceuticals…
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis – Full Text View -.
clinicaltrials.gov
The objective of the study is to evaluate the effect of two doses of Teriflunomide on the frequency of relapses in patients with relapsing multiple sclerosis. The effect on worsening of disability and fatigue will also be evaluated, as well as long term safety.
This study is ongoing, but not recruiting participants.
First Received on May 7, 2008. Last Updated on February 19, 2011 History of Changes
| Sponsor: | Sanofi-Aventis |
|---|---|
| Information provided by: | Sanofi-Aventis |
| ClinicalTrials.gov Identifier: | NCT00751881 |
Purpose
The objective of the study is to evaluate the effect of two doses of Teriflunomide on the frequency of relapses in patients with relapsing multiple sclerosis. The effect on worsening of disability and fatigue will also be evaluated, as well as long term safety.
| Condition | Intervention | Phase |
|---|---|---|
| Multiple Sclerosis | Drug: Teriflunomide (HMR1726) Drug: Placebo |
Phase III |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator) Primary Purpose: Treatment |
| Official Title: | A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis |
Learn more: CLICK HERE
****************************************************************
Know somebody affected by Multiple Sclerosis?
Ask them to remain CURRENT with Multiple Sclerosis information
when registered at the MS Views and News website
.
***************************************************************************************
Help to Educate: Please donate
– all contributions are tax deductible –
.
“Providing You with ‘MS Views and News’, is what we do“
***************************************************************************************
.
Disclaimer: ‘MS Views and News’ (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews